Trials / Completed
CompletedNCT00203086
A Study to Evaluate the Long Term Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple Sclerosis
A Multi-Centered, Two Arm, Open Label Extension Study (to Protocol NC-100) to Evaluate the Long-Term Safety and Efficacy of Short-Term Induction Treatment With Mitoxantrone (Novantrone®) Preceding Treatment With Glatiramer Acetate (Copaxone®) vs. Chronic Treatment With Glatiramer Acetate Alone in Relapsing Forms of Multiple Sclerosis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc. · Industry
- Sex
- All
- Age
- 20 Years – 57 Years
- Healthy volunteers
- Not accepted
Summary
It is thought that treating Multiple Sclerosis with Novantrone for a short period of time prior to treatment with Copaxone may enhance the onset effect of Copaxone.
Conditions
Timeline
- Start date
- 2005-10-01
- Primary completion
- 2009-10-01
- Completion
- 2009-12-01
- First posted
- 2005-09-20
- Last updated
- 2010-04-29
Source: ClinicalTrials.gov record NCT00203086. Inclusion in this directory is not an endorsement.